OXURION NV

OXUR
Real-time Quote. Real-time  - 10/21 03:10:50 am
2.265EUR -0.22%

Turn to zoom
Prev.2.2700
Open2.3400
High2.3400
Low2.2650
Volume4 716
Latest news
7d ago
10/13
10/13
10/11
Chart OXURION NV
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance2,472,642,98
Spread/Res.-8,1%-14%-24%
Spread/Supp.6,8%31%26%
Support2,121,731,80
Financials
Sales 2021 0,25 M 0,29 M 0,29 M
Net income 2021 -32,3 M -37,6 M -37,6 M
Net Debt 2021 - - -
P/E ratio 2021 -2,73x
Yield 2021 -
Capitalization 87,6 M 102 M 102 M
Capi. / Sales 2021 350x
Capi. / Sales 2022 -
Nbr of Employees 66
Free-Float 79,6%
Company
Oxurion NV, formerly known as ThromboGenics NV, is a Belgium-based biopharmaceutical company, which focuses on the development and commercialization of ophthalmic medicines. Its lead product, JETREA (ocriplasmin), has been approved by the United States Food and Drug Administration for the treatment...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-12 Presentation

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 2,27 €
Average target price 9,00 €
Spread / Average Target 296%